Research News and Research

RSS

EHSI announces acquisition of Rotary Cell Culture System

Emerging Healthcare Solutions, Inc. announced today that it has acquired a Rotary Cell Culture System, or bioreactor, developed using revolutionary NASA research in the field of microgravity.

4 Dec 2010

New standard treatment for early stage breast cancer

Spanish Oncology has established a new standard treatment for Breast Cancer at early stages thanks to the results of the study 9805/Target 0 funded by Spanish Breast Cancer Research Group and sponsored by Sanofi Aventis.

4 Dec 2010

Administration offers new guidance to make the small business tax credit more user-friendly

The administration released guidance for the small business tax credit provision of the health law while the AMA asked for specific anti-trust treatment regarding accountable care organizations.

4 Dec 2010

Mitoxantrone increases survival for children with relapsed ALL, trial results show

A new treatment increases survival to almost 70 per cent for children whose acute lymphoblastic leukaemia returns, according to the results of a trial published online in the Lancet today (Saturday).

4 Dec 2010

Obama faces tough talk about the health law from GOP governors, lawmakers

On Thursday, President Obama met with a newly elected governors -- many from the GOP -- to defend his health overhaul plan. It wasn't a completely friendly meeting. Meanwhile, on Capitol Hill, a Republican lawmaker stated his intent to work tirelessly for repeal.

4 Dec 2010

UBC receives $7M grant from Bill & Melinda Gates Foundation for PRE-EMPT Project

The University of British Columbia has received a $7 million grant from the Bill & Melinda Gates Foundation. UBC researchers working at the Child & Family Research Institute will test new strategies for the monitoring, prevention, and treatment of pre-eclampsia.

4 Dec 2010

Zometa improves OS, PFS in newly diagnosed multiple myeloma patients: Phase III study

A newly published study in the Lancet suggested that a first-line treatment regimen including Zometa (zoledronic acid) significantly improved overall survival and progression-free survival in newly diagnosed multiple myeloma patients compared with a regimen that included oral clodronate. The impact on survival was independent of the effect of Zometa on bone complications (also known as skeletal-related events or SREs).

4 Dec 2010

Exposure to nicotine during pregnancy may cause learning disabilities in children: Research

Exposure to nicotine during pregnancy leads to a decrease in adult stem cells and a change in synaptic plasticity in the hippocampus of the offspring, according to new research from the University of Alabama at Birmingham presented at Neuroscience 2010, the annual Society for Neuroscience meeting in San Diego in November.

4 Dec 2010

Study: Some states fall short in insurance rate reviews

A new study finds that states don't always flex their muscle when it comes to regulating insurance rates. Meanwhile, there is movement at the top for WellPoint.

4 Dec 2010

BRI enters 3-year partnership with Roche to develop human immunology programs

Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.

4 Dec 2010

HIV/AIDS opinions

"Promising scientific developments to prevent AIDS, not just treat its victims, have sparked hope among health officials, researchers and advocacy groups struggling to control the epidemic. Unfortunately, the global recession and soaring deficits in advanced nations have made it unlikely that sufficient money will be available to fully seize the new opportunities," according to a New York Times editorial, which postures, "[s]ome agonizing choices will have to be made."

4 Dec 2010

Merck plans to acquire SmartCells

Today pharmaceutical company, Merck & Co., Inc. announced it will acquire SmartCells, Inc., a private biotech developing a glucose-responsive insulin whose proof-of-concept preclinical trials were partially funded by the Juvenile Diabetes Research Foundation.

4 Dec 2010

Review shows need for standardized approach to outcome assessment in breast reconstruction

Improved standards for outcome reporting in breast reconstruction are needed, according to a review published online December 3rd in The Journal of the National Cancer Institute.

4 Dec 2010

Gene mutation can lead to different mental illnesses when influenced by same environmental factor

Male mice born with a genetic mutation that's believed to make humans more susceptible to schizophrenia develop behaviors that mimic other major psychiatric illnesses when their mothers are exposed to an assault to the immune system while pregnant, according to new Johns Hopkins research.

4 Dec 2010

News outlets explore approaches for caring for aging patients

Caring for aging patients -- whether at home or in nursing facilities -- poses unique challenges.

4 Dec 2010

In New York, quiet Medicaid spending talks proceed while a Michigan insurer adds a range of new insurance products

Gov.-elect Andrew Cuomo and the state's health-care union are in quiet talks over Medicaid spending in an effort to avoid a bitter showdown next year over the state budget (Gershman, 12/3).

4 Dec 2010

Alteration in gene causes male embryos to develop as females

Scientists have discovered that the alteration of a single gene could cause some male embryos to develop as females.

4 Dec 2010

Electronic cigarettes are potentially harmful, researchers say

Electronic cigarettes (or e-cigarettes), also called "electronic nicotine delivery systems," are increasingly used worldwide even though only sparse information is available on their health effects. In the United States, e-cigarettes are readily available in shopping malls in most states and on the Internet.

4 Dec 2010

ProPublica: Drug Co. used ghostwriters to pen work bylined by academics

An investigative news piece finds that ghostwriters write medical studies, editorials and other works for a major drug company.

4 Dec 2010

Research findings could provide breakthrough for development of effective therapies for NSCLC

Research at Virginia Commonwealth University Massey Cancer Center led by Charles E. Chalfant, Ph.D., associate professor of biochemistry and molecular Biology, discovered a previously unknown mechanism in non-small cell lung cancer cells that contributes to their ability to maintain and grow tumors. Narrowing in on this mechanism could provide a breakthrough for the development of effective therapies for NSCLC and other cancers.

4 Dec 2010

Research News and Research

EHSI announces acquisition of Rotary Cell Culture System

New standard treatment for early stage breast cancer

Administration offers new guidance to make the small business tax credit more user-friendly

Mitoxantrone increases survival for children with relapsed ALL, trial results show

Obama faces tough talk about the health law from GOP governors, lawmakers

UBC receives $7M grant from Bill & Melinda Gates Foundation for PRE-EMPT Project

Zometa improves OS, PFS in newly diagnosed multiple myeloma patients: Phase III study

Exposure to nicotine during pregnancy may cause learning disabilities in children: Research

Study: Some states fall short in insurance rate reviews

BRI enters 3-year partnership with Roche to develop human immunology programs

HIV/AIDS opinions

Merck plans to acquire SmartCells

Review shows need for standardized approach to outcome assessment in breast reconstruction

Gene mutation can lead to different mental illnesses when influenced by same environmental factor

News outlets explore approaches for caring for aging patients

In New York, quiet Medicaid spending talks proceed while a Michigan insurer adds a range of new insurance products

Alteration in gene causes male embryos to develop as females

Electronic cigarettes are potentially harmful, researchers say

ProPublica: Drug Co. used ghostwriters to pen work bylined by academics

Research findings could provide breakthrough for development of effective therapies for NSCLC

A new way of characterising biomolecules eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest Life Science News